Find clinical trials for Pancreatic Cancer in Philadelphia, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Philadelphia, PA, USA:
receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...
Philadelphia, Pennsylvania, United States and 12 other locations
with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...
Phase 3
Philadelphia, Pennsylvania, United States and 89 other locations
Initial study to evaluate local control and the preferred method of attachment of the CivaSheet in the setting of suspected close or positive margins...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States of America and 4 other locations
A) vs. mFOLFIRINOX plus placebo (Arm B) in 94 subjects with advanced pancreatic cancer, not amenable to curative treatment. Both ar...
Phase 2
Philadelphia, Pennsylvania, United States and 7 other locations
in first line treatment naïve subjects with Stage IV metastatic pancreatic carcinoma. The first part of study will focus on the treatment of ...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 8 other locations
Study of NGM120 in subjects with advanced solid tumors and and pancreatic cancer (Part 1 and 2) and metastatic castration resistant...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 21 other locations
in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma (PDAC) who have been previously untreat...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 10 other locations
and clinical activity of AB680 in combination with Zimberelimab (AB122), nab-paclitaxel and gemcitabine in participants with advanced pancreatic...
Phase 1
Philadelphia, Pennsylvania, United States and 17 other locations
This is a Phase I study evaluating the safety and feasibility of lentiviral transduced huCART-meso cells when given in combination with VCN-01 in a 3...
Phase 1
Philadelphia, Pennsylvania, United States
compared to just chemotherapy alone in participants with metastatic pancreatic cancer. One group of participants will only receive ...
Phase 2
Newark, Delaware, United States and 35 other locations
Clinical trials
Research sites
Resources
Legal